Doug Rice serves as the Chief Financial Officer at MIMEDX GROUP, INC., a leading biomedical company specializing in the development and commercialization of regenerative biologics. With a robust background in finance and strategic planning, Doug has been instrumental in steering MIMEDX towards financial stability and growth. Prior to joining MIMEDX, Doug held several senior financial roles at various companies, where he honed his expertise in financial management and corporate strategy. His career is marked by a consistent track record of improving operational efficiencies and driving profitability. At MIMEDX, Doug's role as CFO encompasses overseeing the company's financial operations, including budgeting, forecasting, and financial reporting. He plays a critical role in shaping the company's financial strategy and ensuring compliance with regulatory standards. Under his leadership, MIMEDX has seen significant improvements in its financial performance, which has been pivotal in supporting the company's mission to advance the science of healing. Doug's strategic vision and financial acumen have been key to MIMEDX's success in navigating the competitive landscape of the biologics industry. Doug's achievements extend beyond his role at MIMEDX. He is known for his ability to foster strong relationships with investors and stakeholders, which has been crucial in securing the necessary capital to fund MIMEDX's innovative projects. His contributions have not only bolstered the company's financial health but have also enhanced its reputation in the industry. Doug's dedication to excellence and his strategic foresight continue to drive MIMEDX's growth and position the company as a leader in regenerative medicine.